Esperion in serious trouble

anonymous

Guest
Everything is contingent on the upcoming clinical trial. If it's not as planned then the company will be totally insolvent. No future potential earnings. If it's good it has a change of capturing 2% of the market which still makes this a huge risk. Management hasn't demonstrated any plan other than gutting the employees and sales. ADVISE TO RUN FROM THIS ONE.
 






Everything is contingent on the upcoming clinical trial. If it's not as planned then the company will be totally insolvent. No future potential earnings. If it's good it has a change of capturing 2% of the market which still makes this a huge risk. Management hasn't demonstrated any plan other than gutting the employees and sales. ADVISE TO RUN FROM THIS ONE.

Many jilted from the lying Scientific Hiring Process, are watching and enjoying the melt down of a failed culture that Esperion created.

Good riddance.
 






Everything is contingent on the upcoming clinical trial. If it's not as planned then the company will be totally insolvent. No future potential earnings. If it's good it has a change of capturing 2% of the market which still makes this a huge risk. Management hasn't demonstrated any plan other than gutting the employees and sales. ADVISE TO RUN FROM THIS ONE.

The upcoming clinical trial is not going to save this company, even if the results are positive.
 






The upcoming clinical trial is not going to save this company, even if the results are positive.
You are so fucking full of shit, do you have any idea what you’re talking about. The data is going to be groundbreaking, transformative and accretive to the clinical benefits that accrue today. You loser were not hired because YOU AREN'T GOOD ENOUGH.
 






Groundbreaking and transformative! here we go with new buzzwords. This trial will lay an egg. You would be better off selling a turd in a paper bag. Hilarious! Thanks for the keen insight Mr Ann Arbor!
 
























The stock continues to get pummeled today as its down 5% and its not even noon yet!! How much longer can we sustain these loses??? $3.94.and dropping hard!! Any pivots? Sustainability?
 






























Down over 3% already this morning. $3.31 and falling. Let's have a meeting !! Let's see the plan!!

Will you stop with the gd stock quotes. If you are holding Esperion....news flash you will or already have lost your money. Good news is you can harvest the loss for tax purposes...of course this assumes you have companies of a higher caliber in your portfolio on which you have gains to offset. Carry on.
 












The fact that sales are terrible means doctors do not buy into CRP reductions or no elevated sugars verse statins. Novartis’s drug game over twice a year verse everyday .
Cocky management during launch, over hiring , paying to high salaries all during Covid proved fatal. Rest In Peace
 






Totally agree on the buffonery of management at launch. The ridiculous retreads that were hired and paying them good 6 figure salaries was a disaster.This was a textbook case of arrogance and incompetence.
 






Totally agree on the buffonery of management at launch. The ridiculous retreads that were hired and paying them good 6 figure salaries was a disaster.This was a textbook case of arrogance and incompetence.

Yes.

Arrogance and Incompetence were both hired through the Scientific Process. Along with numerous retreads.
 






Many jilted from the lying Scientific Hiring Process, are watching and enjoying the melt down of a failed culture that Esperion created.

Good riddance.

Lying Scientific Hiring Process reflects the ability of the interviewers and the credibility of the company hiring process. This is a con man response to accept the fact. GOOD LUCK !!!
 






This has literally unraveled before our eyes the last two years. All the big talk at the cattle call interviews, lying to the extreme, wasting people's time all insured that "what goes around ,comes around". Esperion deserves everything it's received the last two years. What a mess of a company.